Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-18

Clinical Trial Update: Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of combining lercanidipine with valsartan in adults with essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lercanidipine (lercanidipine)
  • VALSARTAN (Valsartan)

Snippet

Sponsor: LG Life Sciences | Conditions: Essential Hypertension | Phase 2 | Status: COMPLETED